BENSALEM, Pa.–(BUSINESS WIRE)–
Law Offices of Howard G. Smith reminds investors of the upcoming October 4, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Curaleaf Holdings, Inc. (“Curaleaf” or the “Company”) (OTC: CURLF) securities between November 21, 2018 and July 22, 2019, inclusive (the “Class Period”).
Investors suffering losses on their Curaleaf investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to firstname.lastname@example.org.
On July 22, 2019, the Company received a warning letter from the FDA, which revealed that the Company was selling unapproved new and misbranded drugs for both human and animal consumption, as well as marketing CBD products improperly as dietary supplements.
On this news, shares of Curaleaf fell $0.58 per share, or over 7%, to close at $7.40 on July 23, 2019, thereby injuring investors.
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that Curaleaf, on its website